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Abstract 
The obesity epidemic has become global meriting the term of “globesity”. at the heart 
of it lies our increasing sedentary lifestyle together with detrimental dietary habits. The 
genetic background, in particular, our “thrifty genes” also take part of the responsibility 
for this pandemia. Interestingly, mounting epidemiological evidence links obesity with 
increases in intrauterine influences, epigenetics, viruses, microbiota, climate changes, 
sleep debt, and xenobiotics including endocrine disruptors, among others. In this re-
spect, it may be worthwhile to consider that all these factors, that conform our lifelong 
exposure profile or “exposome”, may be partly contributing to the global obesity epi-
demic. consequently, an exposomic approach underlines the need for biomonitoring 
of xenobiotics accumulation in human body, particularly in adipose tissue. It may be 
time to try to better identify these potential drivers and stimulate analysis on the im-
pact of the “exposome” in light of the increasing overweight and obesity trends. 
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I am a citizen of the world.
Homo obesus, a paraphrase 
from Diogenes (412-323 BC)
The Global Burden of Metabolic 
Risk Factors of Chronic Diseases 
Collaborating Group reported that in 
adults obesity is increasing worldwide 
despite the fact that many countries 
have successfully reduced blood pres-
sure and have shown that interven-
tions on metabolic mediators might 
partially mitigate the health effects of 
rising the body mass index (1,2). The 
Homo obesus has been described as a 
recent phenotypic expression of the 
Homo sapiens (3,4). In particular, the 
Homo obesus or obese man has been 
classified as a species deficient in me-
tabotrophic factors (metabotrophins), 
including endogenous neurotrophic 
proteins, which play essential roles in 
the maintenance of glucose, lipid, en-
ergy and vascular homeostasis, as well 
as in improving metabolism-related 
processes such as inflammation and 
wound healing (3). 
New insights for better under-
standing population changes and their 
interaction with the environment are 
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therefore welcome. Our “thrifty genes” together with profound 
lifestyle changes, characterized by an energy-dense diet, espe-
cially due to high-fat foods, as well as a stubborn sedentariness 
have been advocated as the main reasons for the escalating 
overweight and obesity trends of the past decades. Nonetheless, 
findings in different scenarios are partially questioning this 
view. On the one hand, the results of the genome-wide associa-
tion scans for obesity-related traits performed by huge consortia 
are probing that the impact of the most relevant genes are in 
reality small (5). Moreover, the adverse genetic make-up can be 
effectively counteracted by physical activity (6,7). Interestingly, 
it has been shown that obesity spreads more through social ties 
than via familial heritage (8), a fact that reinforces the relative 
relevance of genetics. On the other hand, epigenetics has gained 
protagonism in explaining how specific environmental expo-
sures are able to confer an increased risk for the development 
of obesity and other diseases via direct influence on the human 
genome regulation (9). Noteworthy, during the past decades so-
ciocultural circumstances have prompted important reproduc-
tive performance changes that have translated into an increased 
maternal age together with higher fecundity among people with 
elevated adiposity (10). In this respect, it has to be stressed that 
older mothers are at risk of delivering either small or large for 
gestational age babies, and both of them are well-known to be 
more prone to become obese adults. Thus, the detrimental ef-
fect on the baby’s birthweight in either direction conditions the 
likelihood of developing obesity at a later stage, as demonstrated 
by recent studies in developmental programming (11 and refer-
ences therein). Further, the field of energy homeostasis in hu-
mans has experimented a substantial turn with the identification 
of brown adipose tissue in adults (12). The additional possibility 
of stimulation of these brown adipose tissue depots via sympa-
thetic activation as is the case in response to cold exposure (13) 
provides a further plausible link between the obesity pandemia, 
climate change and global warming (14). Another unsuspected 
key player in energy control and metabolism that has gained a 
lot of special attention in the last years is the gut microbiome 
(15). Interestingly, alterations of the gut microbiome are associ-
ated with obesity at the same time as being responsive to weight 
loss since gut microbes can impact host metabolism with effects 
on deposition of energy in fat stores, insulin resistance, and in-
flammation. Conversely, the restoration of the gut microbiota 
to a physiological balance of the different phyla ameliorates the 
derangements accompanying obesity, aiding in the maintenance 
of a normal weight (16). 
Infecto-obesity, i.e. the relation between infectious agents and 
the development of excess weight, has been a topic that has gath-
ered renewed attention as a potential external driver of the obe-
sity pandemia. In this regard, associations between the presence 
of antibodies against in particular adenovirus-36 and Chlamydia 
pneumoniae and the development of obesity have been estab-
lished (17,18). These infectious agents are able to infect fat cells 
and interfere the control of transcription factors and enzymes 
towards triglyceride accumulation as well as differentiation of 
preadipocytes into mature adipocytes. 
The environmental obesogen hypothesis postulates that 
chemical pollutants, such as persistent organic pollutants (POP) 
including pesticides and polychlorinated biphenyls, are able to 
promote obesity by altering homeostatic metabolic set-points, 
disrupting appetite regulation, altering lipid homeostasis to 
promote adipocyte hypertrophy, and/or stimulating adipogenic 
pathways that enhance adipocyte hyperplasia during develop-
ment or adulthood (19). In the same view, endocrine disrupting 
chemicals reportedly are able to trigger endogenous hormonal 
dysregulation that predisposes to weight gain. A number of dif-
ferent endocrine disrupting chemicals are known to interfere 
hormonal signalling key to adipobiology like the organotin 
tributyltin, which exerts high-affinity nuclear hormone recep-
tor-mediated effects on fat cells to favour long-term obesogenic 
changes that translate into epidemiological impact (10,19,20). 
Phthalates, bisphenol A, polybrominated diphenyl ethers, and 
perfluoro-compounds embody potential obesogens exhibiting a 
direct link between exposure, transcriptional network modula-
tion and adipogenic phenotypes. Of note, the levels in humans 
of these compounds are on the rise during the last decades (10). 
Noteworthy, the adipose tissue is the major reservoir of POP, 
also various cancerogenic polycyclic aromatic hydrocarbons, 
which are implicated in the development of obesity-related 
diseases and cancer. Accordingly, xenobiotic-metabolizing cy-
tochromes p450 (CYP) are expressed in adipose tissue. And 
are inducible through mechanisms similar to those in the liver, 
namely, CYP1A1 and CYP1B1 can bioactivate xenoestrogens 
(dioxin and pesticides) and carcinogenic benzo(a)pyrenes). 
Consequently, an adipocentric approach underlines the need for 
human biomonitoring of xenobiotics accumulation in adipose 
tissue. Such studies open a new field of adipobiology that was 
conceptualized as adipotoxicology (21, also see Yanev in this 
volume of Adipobiology).
Circadian regulation of energy homeostasis is controlled 
by an endogenous biological clock that is located in the hypo-
thalamic suprachiasmatic nucleus (SCN). The synchronization 
of photic information that travels directly from light-sensitive 
ganglion cells in the retina to the SCN, accommodates the in-
dividuals’ physiology and behaviour to the external day-night 
cycle. Noteworthy, the increase in the prevalence of globesity 
is paralleled by the elevated exposure to light at night and shift 
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work (22). Light cues are the most potent signals for the circa-
dian clock, while other factors such as food consumption also 
influence clock signalling. By favouring optimal adaptive func-
tioning, the circadian clock conditions subjects to predictable 
circumstances such as sleep and food availability. Consequently, 
clock function disruption produces circadian and metabolic dis-
turbances with alterations in the timing of food intake and other 
metabolic signals, leading to excess weight gain (23). Alterations 
in the chronobiology (also in adipose tissue, see 24) as well as 
sleep curtailment are followed by increases in body mass index 
and undermine dietary effects to decrease adiposity. Thus, sleep 
debt is accompanied by increased hunger, higher plasma levels 
of the orexigenic hormone, ghrelin, and reduced concentrations 
of the anorexigenic hormone, leptin, in volunteers following a 
caloric restriction, but not when they were on a surplus of en-
ergy (25,26). Not surprisingly, lack of sleep is known to exert 
relevant effects on multiple neuroendocrine signals clearly in-
volved in substrate utilization control such as the circulating 
levels of cortisol, catecholamines, thyroid, and growth hormone. 
Last but not least, through a very elegant cross-species analy-
sis the group of Professor Allison has pragmatically shown a plu-
rality of obesity epidemics in mammalians living with or around 
humans (27). Most interestingly, part of these animals were 
obese even when living in animal houses and thus separately of 
humans as well as in the absence of those factors characteristi-
cally perceived as the primary determinants of the human obe-
sity epidemic due to their adverse influence on diet and physical 
activity. Taken together, all this accumulating evidence can lead 
us to consider that the development of obesity over the past dec-
ades is probably influenced by other factors that we have not 
been able to appreciate in their full extension. 
The measure of all the exposures of an individual in a lifetime 
and how those exposures relate to disease is what was designated 
the “exposome”; its analysis has been a logical step forward after 
the human genome mapping success (28). Of great importance 
is the fact that the exposure of a given subject begins before birth 
and finishes with the person’s death. The exposome, therefore, 
includes exposures (internal and external, positive and negative 
ones) during our whole life from our environment, diet, lifestyle, 
and so on, that will interplay with our specific genetic, epige-
netic and physiologic background to finally conform our health 
status (29). In this respect, environmental exposures have been 
shown to play an outstanding role in common chronic diseases 
like cardiometabolic diseases (atherosclerosis, hypertension, 
obesity, type 2 diabetes, metabolic syndrome) and cancer, which 
constitute a major health burden in economically developed 
countries (30). However, due to the complexity of unravelling 
genetic susceptibility with the plentyful potential exposure-dis-
ease associations it is difficult to establish the individual’s expo-
some and its true contribution to the person’s well-being and 
disease. Therefore, it will be important to try to develop the ad-
equate tools and study designs to better identify the contribution 
of the “exposome” to the globesity and its related diseases. This 
is particularly important in the case of childhood and adolescent 
obesity, because due to the longer exposure, the detrimental ef-
fects produced on weight gain and comorbidities are expected to 
translate in more dramatic clinical outcomes (30). 
Altogether, the present Dance Round reminds us that in the 
life of each individual, “I” (human being) can not be detached 
from “my circumstance” (world), which led the great José Ortega 
y Gasset to write in 1914 his famous maxim Yo soy yo y mi cir-
cunstancia (I am I and my circumstance), in his Meditaciones 
del Quijote.
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